Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
Journal Francais D'Ophtalmologie
|
January 1, 1993
[Ocular complications of intracarotid chemotherapies with nitrosourea agents]
J C Rigal-Sastourne, F Bidaux, F Mir, et al.
British Journal of Cancer
|
May 29, 2003
Phase II multicentre study of docetaxel plus 5-fluorouracil in patients with anthracycline-pretreated metastatic breast cancer
A Lortholary, T Delozier, A Monnier, et al.
Gynecologic Oncology
|
September 24, 2009
Weekly combination of topotecan and gemcitabine in early recurrent ovarian cancer patients: a French multicenter phase II study
F Joly, T Petit, P Pautier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 14, 2004
Patient preference for either the EORTC QLQ-C30 or the FACIT Quality Of Life (QOL) measures: a study performed in patients suffering from carcinoma of an unknown primary site (CUP)
C Rodary, V Pezet-Langevin, S Garcia-Acosta, et al.
Documenta Ophthalmologica. Advances in Ophthalmology
|
January 1, 1993
Antioxidant activity of plasma from subjects with and without senile cataract
G Tissié, S Flangakis, L Missotten, et al.
American Journal of Clinical Oncology
|
December 15, 2004
Docetaxel plus 5-fluorouracil in locally recurrent and/or metastatic squamous cell carcinoma of the head and neck: a phase II multicenter study
Dominique Genet, D Cupissol, G Calais, et al.
Bulletin Du Cancer
|
October 15, 1998
[Mitomycin-vinorelbine combination as second-line chemotherapy in metastatic cancer of the breast]
H Bourgeois, F Turpin, M Bouchada, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 17, 2006
Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trial
J-M Ferrero, B Weber, J-F Geay, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 8, 2001
High dose chemotherapy in ovarian cancer
E Pujade-Lauraine, H Curé, C Battista, et al.
The British Journal of Ophthalmology
|
January 20, 1999
Case-control study of the risk factors for age related macular degeneration. France-DMLA Study Group
G Chaine, A Hullo, J Sahel, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
Journal Francais D'Ophtalmologie
|
January 1, 1993
[Ocular complications of intracarotid chemotherapies with nitrosourea agents]
J C Rigal-Sastourne, F Bidaux, F Mir, et al.
British Journal of Cancer
|
May 29, 2003
Phase II multicentre study of docetaxel plus 5-fluorouracil in patients with anthracycline-pretreated metastatic breast cancer
A Lortholary, T Delozier, A Monnier, et al.
Gynecologic Oncology
|
September 24, 2009
Weekly combination of topotecan and gemcitabine in early recurrent ovarian cancer patients: a French multicenter phase II study
F Joly, T Petit, P Pautier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 14, 2004
Patient preference for either the EORTC QLQ-C30 or the FACIT Quality Of Life (QOL) measures: a study performed in patients suffering from carcinoma of an unknown primary site (CUP)
C Rodary, V Pezet-Langevin, S Garcia-Acosta, et al.
Documenta Ophthalmologica. Advances in Ophthalmology
|
January 1, 1993
Antioxidant activity of plasma from subjects with and without senile cataract
G Tissié, S Flangakis, L Missotten, et al.
American Journal of Clinical Oncology
|
December 15, 2004
Docetaxel plus 5-fluorouracil in locally recurrent and/or metastatic squamous cell carcinoma of the head and neck: a phase II multicenter study
Dominique Genet, D Cupissol, G Calais, et al.
Bulletin Du Cancer
|
October 15, 1998
[Mitomycin-vinorelbine combination as second-line chemotherapy in metastatic cancer of the breast]
H Bourgeois, F Turpin, M Bouchada, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 17, 2006
Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trial
J-M Ferrero, B Weber, J-F Geay, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 8, 2001
High dose chemotherapy in ovarian cancer
E Pujade-Lauraine, H Curé, C Battista, et al.
The British Journal of Ophthalmology
|
January 20, 1999
Case-control study of the risk factors for age related macular degeneration. France-DMLA Study Group
G Chaine, A Hullo, J Sahel, et al.
Page
of 7